Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

Dornier MedTech Launches World’s First Smart Lithotripter Using Big Data at American Urology Association Annual Meeting 

Dornier MedTech Launches World's First Smart Lithotripter Using Big Data at American Urology Association Annual Meeting 

— Dornier Delta® III SmartLitho™ offers analytic algorithm to help urologists make evidence-based treatment decisions

Dornier MedTech (Dornier), a global leader in innovative kidney stone management, today announced the launch of Dornier Delta® III SmartLitho™, the world’s first lithotripter system which uses big data in urology, at the American Urology Association (AUA) Annual Meeting 2018.

The new Dornier Delta® III SmartLitho™ can utilize Dornier’s proprietary analytic algorithm, which is able to provide real world data from extracorporeal shockwave lithotripsy (ESWL) treatments of urological stones by validating against a broad set of data points collected globally. The novel algorithm enables urologists to make personalized, evidence-based decisions by assessing historical success rates of treatment modalities as well as identify and balance costs.

Abel Ang, President and CEO of Dornier MedTech said: “As a global leader in innovative kidney stone management, we are excited to be the first in the world to roll out a feature for ESWL users that uses the power of big data and analytics.

“Using Dornier’s data driven technology, urologists using our best-selling lithotripter now have access to a broad range of clinical data points and information to make evidence-based medical decisions. This ultimately can lead to more efficient healthcare delivery and better patient outcomes.”

About 1 in 11 Americans will have a kidney stone at some point in their lifetime, with more than 50% of patients experiencing one or more recurrences. The prevalence of stone diseases doubled over the last 15 years and cost the U.S. health system US$10 billion per year.i,ii

Dornier MedTech will exhibit the new Dornier Delta III SmartLithoTM at booth 1645 at AUA 2018.

SOURCE Dornier MedTech

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!

By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post